Original Research

Published on 12 Dec 2022

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis

in Pharmacology of Infectious Diseases

Nicole F. Maranchick
Mohammad H. Alshaer
Alison G. C. Smith
Teona Avaliani
Mariam Gujabidze
Tinatin Bakuradze
Shorena Sabanadze
Zaza Avaliani
Maia Kipiani
Charles A. Peloquin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1048653

4,767 views
12 citations

Review

Published on 09 Dec 2022

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies

in Pharmacology of Infectious Diseases

Jan-Willem C. Alffenaar
Jurriaan E. M. de Steenwinkel
Andreas H. Diacon
Ulrika S. H. Simonsson
Shashikant Srivastava
Sebastian G. Wicha

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063453

8,590 views
17 citations

Original Research

Published on 01 Dec 2022

PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis

in Pharmacology of Infectious Diseases

Yun He
Chenchen Wang
Qi Liang
Rongjie Guo
Jiaxuan Jiang
Wenhao Shen
Kai Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1048978

3,846 views
7 citations

Original Research

Published on 30 Nov 2022

Prenylated phenolics from Morus alba against MRSA infections as a strategy for wound healing

in Pharmacology of Infectious Diseases

Gabriela Škovranová
Marie Čulenová
Jakub Treml
Lucia Dzurická
Ivana Marova
Alice Sychrová

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1068371

3,159 views
7 citations

Review

Published on 30 Nov 2022

Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19

in Pharmacology of Infectious Diseases

Mahsa Asadi Anar
Elaheh Foroughi
Elika Sohrabi
Samira Peiravi
Yasaman Tavakoli
Mozhgan Kameli Khouzani
Parisa Behshood
Melika Shamshiri
Arezoo Faridzadeh
Kimia Keylani

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1036093

13,269 views
4 citations

Original Research

Published on 30 Nov 2022

Optimizing antimicrobial therapy in urinary tract infections: A focus on urine culture and sensitivity testing

in Pharmacology of Infectious Diseases

Rama Alkhawaldeh
Rana Abu Farha
Khawla Abu Hammour
Eman Alefishat

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1058669

3,718 views
10 citations

Original Research

Published on 24 Nov 2022

Appraisal of selected ethnomedicinal plants as alternative therapies against onychomycosis: Evaluation of synergy and time-kill kinetics

in Pharmacology of Infectious Diseases

Syeda Aroosa Mohsin
Shazia Shaukat
Marya Nawaz
Tofeeq Ur-Rehman
Nadeem Irshad
Muhammad Majid
Syed Shams ul Hassan
Simona Bungau
Humaira Fatima

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1067697

3,324 views
4 citations

Opinion

Published on 16 Nov 2022

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises

in Pharmacology of Infectious Diseases

Prakasini Satapathy
Radha Kanta Ratho
Sunil Sethi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1065124

1,606 views
1 citation

Original Research

Published on 14 Nov 2022

Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections

in Pharmacology of Infectious Diseases

Susanne Jacobsson
Daniel Golparian
Joakim Oxelbark
Wolfgang W. Wicha
Renata Maria Augusto da Costa
Francois Franceschi
David Brown
Arnold Louie
Steven P. Gelone
George Drusano

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1035841

3,047 views
15 citations

Original Research

Published on 11 Nov 2022

Common recognition topology of mex transporters of Pseudomonas aeruginosa revealed by molecular modelling

in Pharmacology of Infectious Diseases

Andrea Catte
Venkata K. Ramaswamy
Attilio Vittorio Vargiu
Giuliano Malloci
Andrea Bosin
Paolo Ruggerone

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1021916

2,446 views
4 citations

Original Research

Published on 11 Nov 2022

Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial

in Pharmacology of Infectious Diseases

Zahra Sahraei
Ali Saffaei
Ilad Alavi Darazam
Jamshid Salamzadeh
Minoosh Shabani
Shervin Shokouhi
Najmeh Sarvmeili
Mohammadreza Hajiesmaeili
Masood Zangi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1041152

3,633 views
3 citations

Review

Published on 11 Nov 2022

Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection

in Pharmacology of Infectious Diseases

Wujun Chen
Yingchun Shao
Xiaojin Peng
Bing Liang
Jiazhen Xu
Dongming Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1035969

3,948 views
9 citations

Opinion

Published on 08 Nov 2022

Emerging pneumonia-like illness “legionellosis” in Argentina in the COVID-19 era: Cause to panic?

in Pharmacology of Infectious Diseases

Ranjan K. Mohapatra
Ahmed Mahal
Venkataramana Kandi
L. V. Simhachalam Kutikuppala
Ashish K. Sarangi
Snehasish Mishra

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063237

1,584 views

Original Research

Published on 08 Nov 2022

The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial

in Pharmacology of Infectious Diseases

Shimaa A. Said
Alsayyed Abdulbaset
Amal A. El-Kholy
Osama Besckales
Nagwa A. Sabri

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1011522

7,858 views
11 citations

Review

Published on 08 Nov 2022

Nanodelivery of antiretroviral drugs to nervous tissues

in Pharmacology of Infectious Diseases

Sodiq Kolawole Lawal
Samuel Oluwaseun Olojede
Oluwaseun Samuel Faborode
Okikioluwa Stephen Aladeyelu
Matome Nadab Matshipi
Sheu Oluwadare Sulaiman
Edwin Coleridge Stephen Naidu
Carmen Olivia Rennie
Onyemaechi Okpara Azu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1025160

3,159 views
4 citations

Original Research

Published on 03 Nov 2022

The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations

in Pharmacology of Infectious Diseases

Qianting Yang
Tao Zhang
Ying Zhang
Dan Sun
Xiaowei Zheng
Qian Du
Xue Wang
Xiaoliang Cheng
Jianfeng Xing
Yalin Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993330

3,923 views
5 citations

Navigation group

Articles

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies

PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis

Prenylated phenolics from Morus alba against MRSA infections as a strategy for wound healing

Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19

Optimizing antimicrobial therapy in urinary tract infections: A focus on urine culture and sensitivity testing

Appraisal of selected ethnomedicinal plants as alternative therapies against onychomycosis: Evaluation of synergy and time-kill kinetics

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises

Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections

Common recognition topology of mex transporters of Pseudomonas aeruginosa revealed by molecular modelling

Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial

Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection

Emerging pneumonia-like illness “legionellosis” in Argentina in the COVID-19 era: Cause to panic?

The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial

Nanodelivery of antiretroviral drugs to nervous tissues

The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations